Injective price surges as trading volume rises and buyers regain control
- Published
- Updated
Injective moved higher on October 16, with one report putting the token above $9 and another describing a larger intraday jump. One item also pointed to a potential test of $9.60, while another said long-term investors would be watching a much higher level before treating the move as a durable shift. A separate report framed the move alongside ETF approval expectations and compared INJ’s performance with NEAR and Sei.
Key claims & sources
Market reaction i
Injective fell 1.3% in the 4 hours after the first headline, after rising 1.0% in the 2 hours before.
48 prices, one every 30 minutes
Coverage timeline
Every piece in order, with the time its news medium declares — if it is not believable we use ours and say so — and what it added to what was already known at that point. Arriving first is not the same as adding something.
Where this sits in the Injective series
| When | What happened | Figure |
|---|---|---|
| 24 days ago | INJ at $9.29 high | today it sits -11.8% from there |
| 31 days ago | INJ at $6.48 low | today it sits +26.4% from there |
From what we have stored, starting 2 months ago.